A Signing of the Convention between NGHA and SFDA to establish a branch office for Pharmacovigilance and Drug Safety Center inside KAMC-JED
Under the patronage His Excellency Dr. Bander Al Kanawi Chief Executive Officer of Ministry National Guard Health Affairs and His Excellency the Chief Executive Officer, Prof. Hisham Al Jadhey Chief Executive Officer of Saudi Food & Drug Authority “SFDA”, a signing of the Convention took place at King Abdulaziz Medical City-Jed to establish a branch office for Pharmacovigilance and Drug Safety Center inside KAMC-JED. The office will serve the purpose of collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products. The main objective is to communicate the findings with SFDA concerning the following:
Early detection of adverse drug reactions.
Detection of increase in frequency of (known) adverse reaction.
Identification of risk factors and possible mechanisms underlying adverse reactions.
Estimation of quantitative aspects of benefit/risk analysis and dissemination of information needed to improve drug prescribing and regulation.
Prevention of adverse drug reactions.
Drug quality surveillance.
Encouraging rational and safe use of drugs.